Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Term PROM induction: prostaglandin gel versus oxytocin
ACTRN12612000093886Phase 3Recruiting
- Sponsor
- Colchester Hospital University NHS Foundation Trust
- Start
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dinoprost and oxytocin in Rupture of amniotic membranes (PROM) (2 arms), sponsored by Colchester Hospital University NHS Foundation Trust. Primary endpoint: Onset of labour without need for further oxytocin. Started Feb 2009; status: recruiting.
02
Drugs
dinoprostoxytocin
03
Conditions
Rupture of amniotic membranes (PROM)
Beyond the preview
Go deeper on ACTRN12612000093886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000093886.